|
|
| August 28, 2018: Dr. John Eikelboom and Dr. C. Michael Gibson Discuss: COMPASS Trial - Bleeding and cancer risk in patients with vascular |
Dr. John Eikelboom and Dr. C. Michael Gibson Discuss: COMPASS Trial - Bleeding and cancer
risk in patients with vascular disease treated with Rivaroxaban
TBD
[ Download video ] |
|
No comments have been submitted
|